Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Alx Oncology Holdings (ALXO) Times Interest Earned (2019 - 2023)

Alx Oncology Holdings' Times Interest Earned history spans 4 years, with the latest figure at $213.22 for Q4 2023.

  • For Q4 2023, Times Interest Earned rose 252.87% year-over-year to $213.22; the TTM value through Dec 2023 reached -$21.58, up 95.97%, while the annual FY2025 figure was -$13.33, 18.61% up from the prior year.
  • Times Interest Earned for Q4 2023 was $213.22 at Alx Oncology Holdings, up from -$136.25 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $213.22 in Q4 2023 and bottomed at -$18340.5 in Q3 2022.
  • The 4-year median for Times Interest Earned is -$139.48 (2022), against an average of -$4412.5.
  • The largest YoY upside for Times Interest Earned was 252.87% in 2023 against a maximum downside of 98.99% in 2023.
  • A 4-year view of Times Interest Earned shows it stood at -$1517.0 in 2019, then crashed by 114.67% to -$3256.6 in 2020, then surged by 95.72% to -$139.48 in 2022, then surged by 252.87% to $213.22 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Times Interest Earned are $213.22 (Q4 2023), -$136.25 (Q3 2023), and -$98.86 (Q2 2023).